Abinitio Bio

Abinitio Bio builds AI foundation models for biopharmaceutical manufacturing, positioning itself as the intelligence layer for drug manufacturing. Its first model, Echo, predicts manufacturing outcomes to assess manufacturability from day one through process scale-up — evaluating molecules early to reduce aggregation and regulatory liabilities, recommending optimal cell lines, media formulations, and bioprocess parameters, predicting process behavior across scales and operating conditions, and delivering lab-validated candidate molecules, processes, and characterization data ready for commercial scale-up. Founded in 2026 in Boston and backed by Y Combinator (Spring 2026), MIT's Researcher-to-Entrepreneur Accelerator, and Fifty Years' 5050 Program. The company operates a B2B model with pharmaceutical companies and CDMOs and does not currently publish a public API or developer platform.

Abinitio Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Artificial Intelligence, Drug Manufacturing, and Machine Learning.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyArtificial IntelligenceDrug ManufacturingMachine LearningPharmaceuticalsFoundation Models

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abinitio-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: abinitio-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abinitio-bio.png
name: Abinitio Bio
description: Abinitio Bio builds AI foundation models for biopharmaceutical manufacturing, positioning itself as the intelligence
  layer for drug manufacturing. Its first model, Echo, predicts manufacturing outcomes to assess manufacturability from day
  one through process scale-up — evaluating molecules early to reduce aggregation and regulatory liabilities, recommending
  optimal cell lines, media formulations, and bioprocess parameters, predicting process behavior across scales and operating
  conditions, and delivering lab-validated candidate molecules, processes, and characterization data ready for commercial
  scale-up. Founded in 2026 in Boston and backed by Y Combinator (Spring 2026), MIT's Researcher-to-Entrepreneur Accelerator,
  and Fifty Years' 5050 Program. The company operates a B2B model with pharmaceutical companies and CDMOs and does not currently
  publish a public API or developer platform.
url: https://raw.githubusercontent.com/api-evangelist/abinitio-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Artificial Intelligence
- Drug Manufacturing
- Machine Learning
- Pharmaceuticals
- Foundation Models
apis: []
common:
- type: DomainSecurity
  url: security/abinitio-bio-domain-security.yml
- type: Website
  url: https://www.abinitio-bio.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Abinitio Bio

Kin Score

Security Posture 1

Abinitio Bio Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)